ID

34470

Descripción

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00922129

Link

https://clinicaltrials.gov/show/NCT00922129

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/5/19 27/5/19 -
  3. 29/5/19 29/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00922129

Eligibility Prostate Cancer NCT00922129

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients ≤ 50 years in their post renal transplant follow-up;
Descripción

ID.1

Tipo de datos

boolean

biopsy confirmed prostate cancer;
Descripción

ID.2

Tipo de datos

boolean

stable renal function with gfr ≥ 40 ml/min.
Descripción

ID.3

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with metastatic disease;
Descripción

ID.4

Tipo de datos

boolean

uncontrolled hyperlipidemia;
Descripción

ID.5

Tipo de datos

boolean

proteinuria > 500 mg/day;
Descripción

ID.6

Tipo de datos

boolean

biopsy evidence of acute rejection within the past 3 months;
Descripción

ID.7

Tipo de datos

boolean

existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
Descripción

ID.8

Tipo de datos

boolean

patients with mental illness;
Descripción

ID.9

Tipo de datos

boolean

inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT00922129

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male patients ≤ 50 years in their post renal transplant follow-up;
boolean
ID.2
Item
biopsy confirmed prostate cancer;
boolean
ID.3
Item
stable renal function with gfr ≥ 40 ml/min.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients with metastatic disease;
boolean
ID.5
Item
uncontrolled hyperlipidemia;
boolean
ID.6
Item
proteinuria > 500 mg/day;
boolean
ID.7
Item
biopsy evidence of acute rejection within the past 3 months;
boolean
ID.8
Item
existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
boolean
ID.9
Item
patients with mental illness;
boolean
ID.10
Item
inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial